BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1761357)

  • 1. The effect of IFN-alpha-Con1 on hepatic cytochrome P-450 and protein synthesis and degradation in hepatic microsomes.
    Moochhala S; Renton KW
    Int J Immunopharmacol; 1991; 13(7):903-12. PubMed ID: 1761357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and depression of cytochrome P-450-dependent mixed-function oxidase by a cloned consensus alpha-interferon (IFN-alpha CON1) in the hamster.
    Moochhala SM; Renton KW; Stebbing N
    Biochem Pharmacol; 1989 Feb; 38(3):439-47. PubMed ID: 2917006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for xanthine oxidase in the loss of cytochrome P-450 evoked by interferon.
    Moochhala SM; Renton KW
    Can J Physiol Pharmacol; 1991 Jul; 69(7):944-50. PubMed ID: 1720069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the synthesis of hepatic cytochrome P-450 by the interferon-inducing agent poly rI.rCi.
    Singh G; Renton KW
    Can J Physiol Pharmacol; 1984 Apr; 62(4):379-83. PubMed ID: 6733584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
    Abu-Bakar A; Moore MR; Lang MA
    Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC.
    Morgan ET
    Biochem Pharmacol; 1991 Jun; 42(1):51-7. PubMed ID: 2069598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppression of hepatic cytochrome P4504A mRNA mediated by the interferon inducer polyinosinic acid.polycytidylic acid.
    Knickle LC; Spencer DF; Renton KW
    Biochem Pharmacol; 1992 Aug; 44(3):604-8. PubMed ID: 1380810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters.
    Fish EN; Banerjee K; Levine HL; Stebbing N
    Antimicrob Agents Chemother; 1986 Jul; 30(1):52-6. PubMed ID: 3019238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.
    Renton KW; Singh G; Stebbing N
    Biochem Pharmacol; 1984 Dec; 33(23):3899-902. PubMed ID: 6508841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by cycloheximide of degradation of cytochrome P-450 in primary cultures of adult rat liver parenchymal cells and in vivo.
    Guzelian PS; Barwick JL
    Biochem J; 1979 Jun; 180(3):621-30. PubMed ID: 486136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatic cytochrome P4502E1 in rats by acetylsalicylic acid or sodium salicylate.
    Damme B; Darmer D; Pankow D
    Toxicology; 1996 Jan; 106(1-3):99-103. PubMed ID: 8571407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential administrations of polyriboinosinic acid and polyribocytidylic acid induce interferon and depress the hepatic cytochrome P-450-dependent monooxygenase system.
    Deloria LB; Mannering GJ
    Biochem Biophys Res Commun; 1982 Jun; 106(3):947-52. PubMed ID: 6180744
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of xanthine oxidase and heme oxygenase and depression of liver drug metabolism by interferon: a study with different recombinant interferons.
    Ghezzi P; Saccardo B; Bianchi M
    J Interferon Res; 1986 Jun; 6(3):251-6. PubMed ID: 3018103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular regulation of ethanol-inducible cytochrome P450-IIEI in hamsters.
    Kubota S; Lasker JM; Lieber CS
    Biochem Biophys Res Commun; 1988 Jan; 150(1):304-10. PubMed ID: 2447892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary amino acids and hepatic microsomal drug metabolism in Syrian hamsters.
    Birt DF; Schuldt GH
    Drug Nutr Interact; 1982; 1(2):177-87. PubMed ID: 6926826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
    Parkinson A; Lasker J; Kramer MJ; Huang MT; Thomas PE; Ryan DE; Reik LM; Norman RL; Levin W; Conney AH
    Drug Metab Dispos; 1982; 10(6):579-85. PubMed ID: 6130903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
    Wroblewski VJ; Gessner T; Olson JR
    Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of coumarin 7-hydroxylase activity in chick embryo liver microsomes.
    Goeger DE; Anderson KE
    Biochem Pharmacol; 1992 Jan; 43(2):363-9. PubMed ID: 1739422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.